IQVIA艾昆纬和百度健康在罕见病领域达成战略合作 构建以患者为中心的数字化解决方案--正本清源 缩短患者旅程

2021-09-11 生物谷 生物谷

IQVIA艾昆纬(下简称“IQVIA”)和百度健康正式达成战略合作,基于罕见病患者全就诊旅程的痛点,以价值医疗为导向,为患者提供一站式的数字化解决方案。

2021年9月11日,在第十届中国罕见病高峰论坛上, IQVIA艾昆纬(下简称“IQVIA”)和百度健康正式达成战略合作,基于罕见病患者全就诊旅程的痛点,以价值医疗为导向,为患者提供一站式的数字化解决方案。
 
百度健康相关负责人毛及表示:“很高兴能携手全球领先的医疗商业解决方案提供方IQVIA,为罕见病患者带去更多希望。作为全网领先的医疗健康科普和服务平台,百度健康将充分发挥自身用户需求入口优势、大数据优势和AI技术优势,为罕见病患者打造精准、权威、专业、全面的知识和服务阵地,为罕见病防治贡献力量。”
 
图说:(左起)IQVIA艾昆纬大中华区数字化商业与医疗解决方案(CSMS)负责人刘飏、中国天使综合征之家负责人张雪、蔻德罕见病中心(CORD)创始人、主任黄如方、浙江大学医学院附属儿童医院神经内科主任医师毛姗姗、百度健康商业化负责人毛及共同呼吁各方携手创新,共筑罕见病生态建设。
 
罕见病患者旅程痛点多 亟待有力数字化解决方案

据不完全统计,目前世界上已经确认的罕见病超过7000种。我国有近2000万的罕见病患者,且每年新增患者超过20万[1]。然而,从诊断、就医、治疗到支付,相对其他患者,罕见病患者的每一个就诊环节都面临更多障碍。例如,由于知晓度低,罕见病最显著的特征就是“确诊难”,有40%的罕见病患者曾被误诊过至少一次[2];患者平均确诊时间超过5年[3]。即使确诊,多数患者也难以筛选、甄别互联网上良莠不齐的医疗信息——如何找到正规且具备诊疗能力的医疗机构;如何找到正规的购药渠道;如何寻求多层次医疗保障和援助的支持——这些都是横亘在罕见病患者旅程上的几座大山。
 
近年来,国家对罕见病防治事业逐步重视,推动出台了《第一批罕见病目录》、《罕见病诊疗指南(2019年版)》等一系列政策,为建设完善的罕见病医疗和保障体系打下了坚实基础。与此同时,随着新冠疫情将互联网医疗推上第二次高速发展的浪潮,各路深耕罕见病领域的医药企业都在积极寻求数字化解决方案,以创新的模式,为罕见病患者提供全病程、全方位的支持。
 
IQVIA携手百度健康,共同打造以患者为中心的数字化解决方案

在此背景之下,IQVIA与百度健康达成战略合作协议,基于IQVIA的专业能力和百度健康的用户需求入口、大数据及AI技术优势,以罕见病患者为中心,共同打造全病程、全方位、一站式的数字化解决方案,包括健康知识服务、在线医疗咨询服务、查询导诊服务、多层次保障和患者援助服务等,最大限度缩短罕见病患者的就医旅程。
 
从疾病教育、疾病预防、早期筛查诊断治疗到康复预后,罕见病患者痛点贯穿个人健康需求全流程。IQVIA副总裁、大中华区商务解决方案总经理邵文斌表示:“由于发病率低且分散,配套资源和设施缺乏,这些痛点在罕见病患者身上尤其显著。此次,IQVIA有幸能与百度健康合作,将科技的能力和专业洞察结合在一起,深刻理解患者需求,并提供全方位的数字化支持,为罕见病防治生态提供有力补充。”
 
未来,双方将持续以患者为中心,并基于数据洞察和客户需求,优化服务方案、拓展业务范畴,为肿瘤自身免疫、疫苗等更多健康领域带来一站式的数字化解决方案,桥接患者未被满足的医疗需求和医药企业数字化转型需求,打造数字健康新生态。
 
 参考资料:
[1] 国家卫生健康委员会.关于印发罕见病诊疗指南(2019年版)的通知:国卫办医函〔2019〕198号 [A/OL]. 2019年2月27日.
[2] 消除罕见病患儿诊断壁垒全球委员会.《消除罕见病患儿诊断壁垒调查结果和建议报告》.
[3] 消除罕见病患儿诊断壁垒全球委员会.《消除罕见病患儿诊断壁垒调查结果和建议报告》.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1988046, encodeId=64c91988046a9, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Mon Mar 28 21:22:44 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363493, encodeId=84f91363493b9, content=<a href='/topic/show?id=46135e6658f' target=_blank style='color:#2F92EE;'>#数字化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57665, encryptionId=46135e6658f, topicName=数字化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467624, encodeId=5da1146e6243e, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478279, encodeId=7b3714e827941, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591907, encodeId=7133159190ec7, content=<a href='/topic/show?id=8e61e186563' target=_blank style='color:#2F92EE;'>#百度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71865, encryptionId=8e61e186563, topicName=百度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0c18038643, createdName=tcm105hq, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016778, encodeId=97101016e7889, content=包装得这么高大上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:21 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016777, encodeId=7d301016e7751, content=扯蛋!不就是通过百度搜索,诱导患者进入某个指定的网站么?!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:14 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016663, encodeId=0b6a1016663a5, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Sep 11 23:45:29 CST 2021, time=2021-09-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1988046, encodeId=64c91988046a9, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Mon Mar 28 21:22:44 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363493, encodeId=84f91363493b9, content=<a href='/topic/show?id=46135e6658f' target=_blank style='color:#2F92EE;'>#数字化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57665, encryptionId=46135e6658f, topicName=数字化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467624, encodeId=5da1146e6243e, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478279, encodeId=7b3714e827941, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591907, encodeId=7133159190ec7, content=<a href='/topic/show?id=8e61e186563' target=_blank style='color:#2F92EE;'>#百度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71865, encryptionId=8e61e186563, topicName=百度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0c18038643, createdName=tcm105hq, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016778, encodeId=97101016e7889, content=包装得这么高大上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:21 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016777, encodeId=7d301016e7751, content=扯蛋!不就是通过百度搜索,诱导患者进入某个指定的网站么?!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:14 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016663, encodeId=0b6a1016663a5, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Sep 11 23:45:29 CST 2021, time=2021-09-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1988046, encodeId=64c91988046a9, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Mon Mar 28 21:22:44 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363493, encodeId=84f91363493b9, content=<a href='/topic/show?id=46135e6658f' target=_blank style='color:#2F92EE;'>#数字化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57665, encryptionId=46135e6658f, topicName=数字化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467624, encodeId=5da1146e6243e, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478279, encodeId=7b3714e827941, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591907, encodeId=7133159190ec7, content=<a href='/topic/show?id=8e61e186563' target=_blank style='color:#2F92EE;'>#百度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71865, encryptionId=8e61e186563, topicName=百度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0c18038643, createdName=tcm105hq, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016778, encodeId=97101016e7889, content=包装得这么高大上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:21 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016777, encodeId=7d301016e7751, content=扯蛋!不就是通过百度搜索,诱导患者进入某个指定的网站么?!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:14 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016663, encodeId=0b6a1016663a5, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Sep 11 23:45:29 CST 2021, time=2021-09-11, status=1, ipAttribution=)]
    2021-09-13 syscxl
  4. [GetPortalCommentsPageByObjectIdResponse(id=1988046, encodeId=64c91988046a9, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Mon Mar 28 21:22:44 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363493, encodeId=84f91363493b9, content=<a href='/topic/show?id=46135e6658f' target=_blank style='color:#2F92EE;'>#数字化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57665, encryptionId=46135e6658f, topicName=数字化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467624, encodeId=5da1146e6243e, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478279, encodeId=7b3714e827941, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591907, encodeId=7133159190ec7, content=<a href='/topic/show?id=8e61e186563' target=_blank style='color:#2F92EE;'>#百度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71865, encryptionId=8e61e186563, topicName=百度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0c18038643, createdName=tcm105hq, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016778, encodeId=97101016e7889, content=包装得这么高大上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:21 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016777, encodeId=7d301016e7751, content=扯蛋!不就是通过百度搜索,诱导患者进入某个指定的网站么?!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:14 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016663, encodeId=0b6a1016663a5, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Sep 11 23:45:29 CST 2021, time=2021-09-11, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1988046, encodeId=64c91988046a9, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Mon Mar 28 21:22:44 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363493, encodeId=84f91363493b9, content=<a href='/topic/show?id=46135e6658f' target=_blank style='color:#2F92EE;'>#数字化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57665, encryptionId=46135e6658f, topicName=数字化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467624, encodeId=5da1146e6243e, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478279, encodeId=7b3714e827941, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591907, encodeId=7133159190ec7, content=<a href='/topic/show?id=8e61e186563' target=_blank style='color:#2F92EE;'>#百度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71865, encryptionId=8e61e186563, topicName=百度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0c18038643, createdName=tcm105hq, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016778, encodeId=97101016e7889, content=包装得这么高大上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:21 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016777, encodeId=7d301016e7751, content=扯蛋!不就是通过百度搜索,诱导患者进入某个指定的网站么?!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:14 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016663, encodeId=0b6a1016663a5, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Sep 11 23:45:29 CST 2021, time=2021-09-11, status=1, ipAttribution=)]
    2021-09-13 tcm105hq
  6. [GetPortalCommentsPageByObjectIdResponse(id=1988046, encodeId=64c91988046a9, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Mon Mar 28 21:22:44 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363493, encodeId=84f91363493b9, content=<a href='/topic/show?id=46135e6658f' target=_blank style='color:#2F92EE;'>#数字化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57665, encryptionId=46135e6658f, topicName=数字化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467624, encodeId=5da1146e6243e, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478279, encodeId=7b3714e827941, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591907, encodeId=7133159190ec7, content=<a href='/topic/show?id=8e61e186563' target=_blank style='color:#2F92EE;'>#百度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71865, encryptionId=8e61e186563, topicName=百度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0c18038643, createdName=tcm105hq, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016778, encodeId=97101016e7889, content=包装得这么高大上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:21 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016777, encodeId=7d301016e7751, content=扯蛋!不就是通过百度搜索,诱导患者进入某个指定的网站么?!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:14 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016663, encodeId=0b6a1016663a5, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Sep 11 23:45:29 CST 2021, time=2021-09-11, status=1, ipAttribution=)]
    2021-09-12 病毒猎手

    包装得这么高大上!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1988046, encodeId=64c91988046a9, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Mon Mar 28 21:22:44 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363493, encodeId=84f91363493b9, content=<a href='/topic/show?id=46135e6658f' target=_blank style='color:#2F92EE;'>#数字化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57665, encryptionId=46135e6658f, topicName=数字化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467624, encodeId=5da1146e6243e, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478279, encodeId=7b3714e827941, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591907, encodeId=7133159190ec7, content=<a href='/topic/show?id=8e61e186563' target=_blank style='color:#2F92EE;'>#百度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71865, encryptionId=8e61e186563, topicName=百度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0c18038643, createdName=tcm105hq, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016778, encodeId=97101016e7889, content=包装得这么高大上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:21 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016777, encodeId=7d301016e7751, content=扯蛋!不就是通过百度搜索,诱导患者进入某个指定的网站么?!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:14 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016663, encodeId=0b6a1016663a5, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Sep 11 23:45:29 CST 2021, time=2021-09-11, status=1, ipAttribution=)]
    2021-09-12 病毒猎手

    扯蛋!不就是通过百度搜索,诱导患者进入某个指定的网站么?!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1988046, encodeId=64c91988046a9, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Mon Mar 28 21:22:44 CST 2022, time=2022-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1363493, encodeId=84f91363493b9, content=<a href='/topic/show?id=46135e6658f' target=_blank style='color:#2F92EE;'>#数字化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57665, encryptionId=46135e6658f, topicName=数字化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e05e201, createdName=appleandpeer, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467624, encodeId=5da1146e6243e, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1478279, encodeId=7b3714e827941, content=<a href='/topic/show?id=5e295415950' target=_blank style='color:#2F92EE;'>#战略合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54159, encryptionId=5e295415950, topicName=战略合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba6c7422782, createdName=ms8435843352634314, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591907, encodeId=7133159190ec7, content=<a href='/topic/show?id=8e61e186563' target=_blank style='color:#2F92EE;'>#百度#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71865, encryptionId=8e61e186563, topicName=百度)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0c18038643, createdName=tcm105hq, createdTime=Mon Sep 13 11:22:44 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016778, encodeId=97101016e7889, content=包装得这么高大上!, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:21 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016777, encodeId=7d301016e7751, content=扯蛋!不就是通过百度搜索,诱导患者进入某个指定的网站么?!, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sun Sep 12 15:23:14 CST 2021, time=2021-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016663, encodeId=0b6a1016663a5, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Sep 11 23:45:29 CST 2021, time=2021-09-11, status=1, ipAttribution=)]
    2021-09-11 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

相关资讯

“救少数人还是救更多人”?罕见病保障机制落地路在何方?

12月,大雪时节刚过,北风萧瑟寒意涌起。比起寒冬时节,让罕见病患者更难以接受的是,罕见病药再次无缘今年的医保谈判。“想通过谈判砍价来稳定药价,这下好了,连谈判机会都不给了。”法

明年1月1日起,一大批抗癌原料药、罕见病原料药将零关税

财政部发布了《国务院关税税则委员会关于2021年关税调整方案》(以下简称方案)

Sarepta公司第3款反义寡核苷酸疗法获FDA批准上市

2月25日,罕见病精准基因治疗领域领导者Sarepta公司宣布,FDA已批准反义寡核苷酸药物AMONDYS 45 (casimersen)上市,用于45外显子跳跃突变杜氏肌营养不良症(DMD)患者治疗

小儿黑色素瘤不是一种疾病,而是多种疾病!

小儿黑色素瘤是一种罕见的疾病,美国每年仅诊断出约400例病例。

Nature Communications:不止疫苗,mRNA技术还能治疗罕见遗传病

2021年5月25日,美国Moderna公司的罕见病研究团队在 Nature Communications 期刊发表了题为:mRNA therapy restores euglycemia and p